Hyperplasia

Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms

... percent in the drug market for benign prostatic hyperplasia and male lower urinary tract symptoms in the ... new Pharmacor report entitled Benign Prostatic hyperplasia and Male Lower Urinary Tract Symptoms finds that ... disease, drug development for benign prostatic hyperplasia has focused on improving dosing convenience and ...

Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men

... to raise awareness of Benign Prostatic hyperplasia (BPH), a condition affecting more than 8 ... the U.S. to raise awareness of Benign Prostatic hyperplasia (BPH), commonly known as enlarged prostate, and ... by sanofi-aventis. About Benign Prostatic hyperplasia (BPH) BPH is defined as a progressive condition ...

COX-2 expression is marker for cancer development in some benign breast biopsies

... they dont have cancer, they do have atypical hyperplasia -- cells that arent quite normal and might become ... 1991, and who were diagnosed with the atypical hyperplasia cell growth disorder. During an average ... cancer 15 years after a diagnosis of atypical hyperplasia was 13 percent in biopsies with little or no ...

Patent Expiries of Proscar and Flomax/Harnal Will Cause a Significant Decline in Near-Term Sales of Benign Prostatic Hyperplasia Drugs

... in sales of therapies to treat benign prostatic hyperplasia over the next five years. The new Pharmacor report entitled Benign Prostatic hyperplasia finds that the market to treat the disease is ... decline in the overall benign prostatic hyperplasia market by 2011. Although patent expiries will ...

Tadalafil May Effectively Treat Symptoms of BPH-LUTS in Addition to Erectile Dysfunction

... may improve lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH). Researchers from Nashville, Dallas, San Antonio and Indianapolis ... obstruction index in men with signs and symptoms of benign prostatic hyperplasia treated with tadalafil. J Urol, suppl. 2009: 181, 4, abstract 1924. ...

Lumenis Introduces the HoLEP Simulator and the PolyScope Disposable Ureteroscope at American Urology Association 2009 Annual Meeting

... superior outcomes and long term durability in treating Benign Prostatic hyperplasia (BPH) of all gland sizes(2). There has been increasing interest from ... first holmium laser cleared by the FDA for treatment of Benign Prostatic hyperplasia (BPH), is also effective for surgical removal of stones, tumors and ...

More>>

Hyperplasia in Medical Technology

Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms

... from placebo and the rate of endometrial hyperplasia in doses being considered for therapeutic use was ... of the SMART-1 trial was incidence of endometrial hyperplasia at one year. Secondary end points included bone ... use were associated with rates of endometrial hyperplasia <1%. These rates were not significantly ...

Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia

... channel protein), to treat benign prostatic hyperplasia (BPH). D-3263 demonstrated the ability to reduce ... (p=0.004) of mean prostate weight and prostate hyperplasia with evidence of a dose response. In addition, ... system. It is over-expressed in prostate hyperplasia and multiple types of cancer including prostate ...

Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer

... applicability to multiple types of cancer as well as to benign prostatic hyperplasia (BPH)," stated Mark Frohlich, M.D., senior vice president of clinical ... a gland in the male reproductive system. It is over-expressed in prostate hyperplasia and multiple types of cancer including prostate cancer, breast cancer, ...

Light Sciences Oncology Raises $40.1 Million in Series C Financing

... Colorectal Cancer and Phase I/II and Phase IIa Benign Prostatic hyperplasia Studies BELLEVUE, Wash., July 15 /PRNewswire/ -- Light Sciences ... Litx platform to include benign neoplasms such as benign prostatic hyperplasia (BPH), neurofibromas, and uterine fibroids, as well as vascular disease ...

Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate

... announced that it has begun treatment of patients with benign prostatic hyperplasia (BPH), or enlargement of the prostate, using Light Infusion Therapy(TM) ... Litx platform to include benign neoplasms such as benign prostatic hyperplasia (BPH), neurofibromas, and uterine fibroids, as well as vascular disease ...

Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder

... involving silodosin, an investigational treatment for benign prostatic hyperplasia (BPH, or prostate enlargement) and a pharmacokinetic study of oxybutynin ... in the US for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). About Oxybutynin Chloride Topical Gel (OTG) OTG is a clear, ...

More>>

Hyperplasia in Medical Products

Aldosterone RIA Test

Description:... renin secretion [3,6]. Abnormally low aldosterone secretion occurs in a number of conditions including salt-wasting forms of congenital adrenal hyperplasia and renin deficiency [4,7,8]. References 1. Crabb J. Mol Cell Endocrinol 90:C11-C13, 1992. 2. Morris DJ. Endocrin Rev 2:234-247, ...
Company:Diagnostic Systems Laboratories, Inc.

Androstanediol Glucuronide RIA Test

Description:... G is derived from DHEA-Sulfate and androstenedione. Elevated levels of serum 3alpha-diol G have been reported in congenital adrenal hyperplasia [3,4] and in various forms of female hirsutism [1,5,6], e.g. idiopathic hirsutism and polycystic ovary disease. Serum 3alpha-diol G may be elevated ...
Company:Diagnostic Systems Laboratories, Inc.

Androstanediol Glucuronide EIA Test

Description:... G is derived from DHEA-Sulfate and androstenedione. Elevated levels of serum 3alpha-diol G have been reported in congenital adrenal hyperplasia [3,4] and in various forms of female hirsutism [1,5,6], e.g. idiopathic hirsutism and polycystic ovary disease. Serum 3alpha-diol G may be elevated ...
Company:Diagnostic Systems Laboratories, Inc.

Androstenedione EIA Test

Description:... provides a useful marker of androgen biosynthesis. Elevated androstenedione levels have been demonstrated in virilizing congenital adrenal hyperplasia [4]. Serum androstenedione levels are also increased in polycystic ovary syndrome, ovarian stromal hyperthecosis, 3b-hydroxysteroid dehydrogenase ...
Company:Diagnostic Systems Laboratories, Inc.

Androstenedione RIA Test

Description:... provides a useful marker of androgen biosynthesis. Elevated androstenedione levels have been demonstrated in virilizing congenital adrenal hyperplasia [4]. Serum androstenedione levels are also increased in polycystic ovary syndrome, ovarian stromal hyperthecosis, 3b-hydroxysteroid dehydrogenase ...
Company:Diagnostic Systems Laboratories, Inc.

Calcitonin IRMA Test

Description:... a meal may play a role in maintaining postprandial calcium homeostasis. Abnormally elevated levels of calcitonin are characteristic of thyroid C-cell hyperplasia and medullary thyroid carcinoma [2,3]. Elevated serum calcitonin levels may also occur in a variety of other malignancies, possibly due to ectopic ...
Company:Diagnostic Systems Laboratories, Inc.

More>>

Hyperplasia in Medical Definition

Pathology

... to chromosomes from radiation or chemicals. hyperplasia is a long-term adaptive response of cell ... skin can cause a protective thickening due to hyperplasia of the epidermis . Hypertrophy is an increase ... Pseudo-Cushing's syndrome ) - Congenital adrenal hyperplasia ( due to 21-hydroxylase deficiency ) - ...

Hyperplasia in Medical Dictionary

Adrenal Hyperplasia

... Congenital Adrenal hyperplasia is the most common cause of ambiguous genitalia ... reproductive structures. Congenital adrenal hyperplasia Definition: Congenital adrenal hyperplasia refers to a group of inherited disorders ...

Benign

... head. Prostate Health Benign Prostatic hyperplasia Phytochemicals : Can They Help Your BPH ? Summary & Participants ... Benign Prostatic hyperplasia : A Common Part of Aging It is common for the ... Doctors call this condition benign prostatic hyperplasia ( BPH ), or benign prostatic hypertrophy . ...

Benign Prostatic Hyperplasia

... Benign prostatic hyperplasia : Abbreviated BPH . A noncancerous prostate ... number. Prostate Health Benign Prostatic hyperplasia Phytochemicals : Can They Help Your BPH ? Summary & Participants ... Benign prostatic hyperplasia Dr Rob Hicks Benign ...

Bph

... ages. This condition is called benign prostatic hyperplasia ( BPH ) or benign prostatic hypertrophy . As ... . BPH ; Benign prostatic hypertrophy ( hyperplasia ); Prostate - enlarged Causes, incidence , and ... for their mild BPH . Benign prostatic hyperplasia ( BPH ) This condition particularly affects ...

Endocrine

... glands develop excess normal tissue ( hyperplasia ) or adenoma ( tumor ): the parathyroid, the ... Hypothyroidism or Congenital Adrenal hyperplasia , two disorders which need prompt diagnosis and ... ad renal , or parathyroid, develop overgrowth ( hyperplasia ) or malignant cells ( cancer ). Islet Cell ...

Granuloma inguinale

... Lymph ography ( Lymphangiogram ) Lymph oid hyperplasia Lymph oid Hypertrophy ( Lymph oid hyperplasia ) ... Genital herpes simplex Syphilis , ... Lymphogranuloma venereum Lymph oid hyperplasia Lymph oid hypertrophy Lymphoma - brain ...

More>>

Hyperplasia in Biological News

First comprehensive guidelines for managing medullary thyroid carcinoma published in Thyroid journal

... are familial and present as an autosomal inherited disorder. In individuals with the inherited form of MTC, a preneoplastic lesion called C-cell hyperplasia will first develop and then progress to an invasive, life-threatening malignancy. The American Thyroid Association ( www.thyroid.org ) has ...

A compound extracted from olives inhibits cancer cells growth and prevents their appearance

... inhibitor that, among other features, has the capacity of regulating cell growth. It is useful for cancer treatment, as it allows to control the hyperplasia and hypertrophy processes, typical of this disease . The scientists of the UGR have characterized for the first time maslinic acid action from the ...

A giant among minnows: Giant danio can keep growing

... phase of the study, the researchers found that hyperplasia accounts for 67 percent of the giant danio’s muscle growth, compared to the zebrafish in which hyperplasia accounts for only 47 percent of the growth. ... zebrafish did not exhibit increased growth or hyperplasia in response to growth hormone, suggesting that ...

Inflammation and drugs to control this activity studied in a variety of tumors sites

... 39 percent (54/144) showed PAH/PIA (post-atrophic hyperplasia and/or proliferative inflammatory atrophy, which ... Risk: Abstract No. 2353 Women with atypical hyperplasia who also have high levels of the enzyme COX-2 in ... biopsy. Of this group, 235 women had atypical hyperplasia and tissue available for the study. Cancer ...

Hair-growth drug artificially lowers PSA levels in prostate cancer screening, study finds

... interpretation by multiplying it times two for these men." Finasteride was initially developed in the 1990s for the treatment of benign prostatic hyperplasia (BPH), better known as enlarged-prostate disease, and was first approved by the U.S. Food and Drug Administration for this use. Patients with BPH ...

Exposure to dioxins influences male reproductive system, study of Vietnam veterans concludes

... prostate in humans like they do in animals." The researchers found that veterans exposed to dioxin had lower incidence rates of benign prostate hyperplasia (BPH), better known as enlarged-prostate disease. BPH is a disease in humans that is caused by an enlargement of the prostate. Patients must strain ...

More>>

Hyperplasia in Biological Technology

AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule

... 041) of its Phase 3 program in benign prostatic hyperplasia (BPH) with its lead endocrinology compound, ... through Shionogi. About Benign Prostatic hyperplasia Benign prostatic hyperplasia (BPH) is one of the most common diseases of aging ...

AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia

... pamoate for the treatment of benign prostatic hyperplasia (BPH), a benign enlargement of the prostate, ... through Shionogi. About Benign Prostatic hyperplasia Benign prostatic hyperplasia (BPH) is one of the most common diseases of aging ...

AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia

... and marketing of cetrorelix in benign prostatic hyperplasia (BPH) for the U.S. market. Cetrorelix, a ... through Shionogi. About Benign Prostatic hyperplasia Benign prostatic hyperplasia (BPH) is one of the most common diseases of aging ...

Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting

... have not been found in normal individuals or those with benign prostate hyperplasia (BPH). However, multiple partner genes, including ETS transcription genes, ... (IDE) to identify patients with prostate cancer vs. benign prostatic hyperplasia (BPH). Although work is needed to improve plasma RNA quality, the ...

Dendreon Presents Preclinical Data Validating Anti-Tumor Activity of D-3263, a Trp-p8 Agonist

... Validation of the TrpM8 Ion Channel as a Cancer/ Benign Prostate hyperplasia Target," was presented at the European Organization for Research and ... therapy for cancer and also potentially for benign prostatic hyperplasia (BPH)," said David Urdal, Ph.D., chief scientific officer of Dendreon. ...

AEterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia

... Company's second efficacy trial of its Phase 3 program in benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate, with its flagship ... and Europe. About Benign Prostatic Hyperplasia Benign prostatic hyperplasia (BPH) is one of the most common diseases of aging men - affecting more ...

Hyperplasia in Biological Definition

Cancer

... detect a condition called "hyperplasia". hyperplasia refers to tissue growth based on an excessive ... the tissue remain normal, and the process of hyperplasia is potentially reversible. hyperplasia can be a normal tissue response to an irritating ...

Hyperplasia in Biological Dictionary

Prostate gland

... options from the American Academy ... Since the prostate gland and the lymph nodes are not taken out, your doctor ... Benign prostatic hyperplasia is commonly known as an enlarged prostate gland . ... As a result, the prostate gland begins to press on the urethra like a clamp. ... ...

Gastrin

... with the last five C-terminal residues. ... Gastrin ... and intestinal acidity rises, gastrin production normally decreases. ... G-cell hyperplasia (overactivity of gastrin -producing cells in the stomach) ... Gastrin is the major hormone that regulates acid secretion in the stomach. ......